Literature DB >> 10482688

S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.

Y Kawarada1, S Isaji, H Taoka, M Tabata, B C Das, H Yokoi.   

Abstract

Recently we have been performing S4a + S5 with total resection of the caudate lobe (S1) by using a dome-like dissection along the root of the middle hepatic vein at the pinnacle, which we refer to as the Taj Mahal liver parenchymal resection, for carcinoma of the biliary tract. This procedure offers the following advantages: (1) It allows total resection of the caudate lobe, including the paracaval portion (S9), and (2) because the cut surface of the liver is large, it allows intrahepatic jejunostomy to be performed more easily with a good field of view. The indications for this procedure include hilar bile duct carcinoma, gallbladder carcinoma, and choledochal cyst (type IVA). Because of the high rate of hilar liver parenchyma and caudate lobe invasion associated with hilar bile duct carcinoma, the liver must be resected. The Taj Mahal procedure is indicated in cases where extended liver resection is impossible. The dissection limits of this procedure are, on the left side, the B2+3 bifurcation at the right margin of the umbilical portion of the portal vein and, on the right side, the B8 of the anterior branch and the B6+7 bifurcation of the right posterior branch. This procedure could also be described as a reduced form of extended right hepatectomy and extended left hepatectomy. For gallbladder carcinoma, this procedure is indicated to ensure an adequate surgical margin and eradicate transvenous liver metastasis, particularly in cases of pT2 lesions. Hilar and caudate lobe invasion also occurs in liver bed-type gallbladder carcinoma, and bile duct resection and caudate lobe resection are required for the surgery to be curative. We performed this procedure in four cases of hilar bile duct carcinoma, five cases of gallbladder carcinoma, and one case each of choledochal cyst (type IVA) with carcinoma of the bile duct and gallbladder adenomyomatosis. Curative resection was possible in all except the patient with adenomyomatosis, and all of the patients are alive and recurrence free 10 to 37 months postoperatively. This procedure, in addition to preserving liver function, provides a wide field of view and facilitates reconstruction of multiple intrahepatic bile ducts. Thus it can be said to be a curative operation not only in patients considered high risk but also in those whose hilar bile duct carcinoma is limited to the bifurcation area (Bismuth type IIIa and IIIb) and in gallbladder carcinoma up to pT2 with slight extension on the hepatic side.

Entities:  

Mesh:

Year:  1999        PMID: 10482688     DOI: 10.1016/s1091-255x(99)80052-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  10 in total

1.  [Preoperative percutaneous transhepatic portal vein embolization to extend the indications for hepatectomy and to increase the safety of extended hepatectomy for hepatocellular carcinoma].

Authors:  H Tanaka; H Kinoshita; K Hirohashi; S Kubo; N Fujio; R Iwasa; K C Lee
Journal:  Nihon Geka Gakkai Zasshi       Date:  1992-10

Review 2.  Research into the results of resection of hilar bile duct cancer.

Authors:  E J Boerma
Journal:  Surgery       Date:  1990-09       Impact factor: 3.982

3.  Management strategies in resection for hilar cholangiocarcinoma.

Authors:  H Bismuth; R Nakache; T Diamond
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

4.  Segments I and IV resection as a new approach for hepatic hilar cholangiocarcinoma.

Authors:  M Miyazaki; H Ito; K Nakagawa; S Ambiru; H Shimizu; Y Shimizu; A Okuno; S Nozawa; Y Nukui; H Yoshitomi; N Nakajima
Journal:  Am J Surg       Date:  1998-03       Impact factor: 2.565

5.  Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival.

Authors:  T Tsuzuki; M Ueda; S Kuramochi; S Iida; S Takahashi; H Iri
Journal:  Surgery       Date:  1990-09       Impact factor: 3.982

6.  Percutaneous transhepatic portal embolization using newly devised catheters: preliminary report.

Authors:  M Nagino; Y Nimura; N Hayakawa
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

7.  Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts.

Authors:  L H Blumgart; N S Hadjis; I S Benjamin; R Beazley
Journal:  Lancet       Date:  1984-01-14       Impact factor: 79.321

8.  Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus.

Authors:  Y Nimura; N Hayakawa; J Kamiya; S Kondo; S Shionoya
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

9.  Central hepatic resection and anastomosis for stricture or carcinoma at the hepatic bifurcation.

Authors:  M J Hart; T T White
Journal:  Ann Surg       Date:  1980-09       Impact factor: 12.969

10.  Proximal bile duct cancer. Quality of survival.

Authors:  E C Lai; R K Tompkins; L L Mann; J J Roslyn
Journal:  Ann Surg       Date:  1987-02       Impact factor: 12.969

  10 in total
  9 in total

1.  Comparative study of perioperative management of hepatic resection.

Authors:  K Akashi; S Mizuno; S Isaji
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

Review 2.  [Resection of Klatskin tumors].

Authors:  D Seehofer; C Kamphues; P Neuhaus
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

3.  Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies.

Authors:  Yoshifumi Kawarada; Bidhan C Das; Tatsushi Naganuma; Masami Tabata; Hiroki Taoka
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

4.  Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma.

Authors:  Jin Hong Lim; Gi Hong Choi; Sung Hoon Choi; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

5.  Is parenchyma-preserving hepatectomy a noble option in the surgical treatment for high-risk patients with hilar bile duct cancer?

Authors:  Hiroshi Shimada; Itaru Endo; Mitsutaka Sugita; Hideki Masunari; Yoshiro Fujii; Kuniya Tanaka; Hitoshi Sekido; Shinji Togo
Journal:  Langenbecks Arch Surg       Date:  2003-02-28       Impact factor: 3.445

Review 6.  Current surgical treatment for bile duct cancer.

Authors:  Yasuji Seyama; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

7.  Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.

Authors:  Peter Neuhaus; Sven Jonas; Utz Settmacher; Armin Thelen; Christoph Benckert; Enrique Lopez-Hänninen; Rainer E Hintze
Journal:  Langenbecks Arch Surg       Date:  2003-06-18       Impact factor: 3.445

8.  Cholangiocellular carcinoma--the role of caudate lobe resection and mesohepatectomy.

Authors:  Massimo Malago; Andrea Frilling; Jun Li; Hauke Lang; Christoph E Broelsch
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

9.  A New Surgical Procedure "Dumbbell-Form Resection" for Selected Hilar Cholangiocarcinomas With Severe Jaundice: Comparison With Hemihepatectomy.

Authors:  Shuguang Wang; Feng Tian; Xin Zhao; Dajiang Li; Yu He; Zhihua Li; Jian Chen
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.